Mannitol Side Effects
Post Side Effect
Ask Community
Compare Side Effects
Post Your Mannitol Experience:
Recent Mannitol Side Effect Reports
Mannitol Side Effects Report #5152522-6
Physician from UNITED STATES reported Mannitol side effect on Oct 13, 2006. Male patient, 64 years of age, weighting 141.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, thrombocytopenia, tumour lysis syndrome. Mannitol dosage: 2.5 MG, OTHER. During the same period patient was treated with GEMZAR, CISPLATIN, DEXAMETHASONE. Patient died on 10/19/2006.
Mannitol Side Effects Report #5404974-1
Mannitol side effect was reported by a Consumer or non-health professional from UNITED STATES on July 22, 2007. Female patient, 54 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE ECTION, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Physician from UNITED STATES reported Mannitol side effect on Oct 13, 2006. Male patient, 64 years of age, weighting 141.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, thrombocytopenia, tumour lysis syndrome. Mannitol dosage: 2.5 MG, OTHER. During the same period patient was treated with GEMZAR, CISPLATIN, DEXAMETHASONE. Patient died on 10/19/2006.
Mannitol Side Effects Report #5404974-1
Mannitol side effect was reported by a Consumer or non-health professional from UNITED STATES on July 22, 2007. Female patient, 54 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE ECTION, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
View More
View All Mannitol FDA Adverse ReportsMannitol Side Effects
Go to the top of the page
Mannitol Questions
Ask Community about Mannitol:
Comments to date: 1. Page 1 of 1.
Rebecca Thomas California | 9:32pm on Sunday, May 17th, 2009 |
What are the risks when taking Mannitol and you currently have Pneumonia? For children under the age... read more » | |
Ask Community about Mannitol:
Questions to date: 1. Page 1 of 1.
Natalie Jurczyk Missouri | 3:51pm on Wednesday, October 21st, 2009 |
Mannitol Adverse Effect Reports (FDA)
Consumer or non-health professional from UNITED STATES reported Mannitol side effect on July 22, 2007. Female patient, 57 years of age, was diagnosed with brain operation, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE ECTION, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5404977-7
Mannitol side effect was reported by a Health Professional from UNITED STATES on July 22, 2007. Female patient, 65 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5404978-9
Health Professional from UNITED STATES reported Mannitol side effect on July 22, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: macular oedema, maculopathy, visual disturbance. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5404982-0
Mannitol side effect was reported by a Health Professional from UNITED STATES on July 22, 2007. Female patient, 66 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: macular oedema, maculopathy, visual acuity reduced. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5404984-4
Health Professional from UNITED STATES reported Mannitol side effect on July 22, 2007. Female patient, 73 years of age, was diagnosed with brain operation, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5404985-6
Mannitol side effect was reported by a Health Professional from UNITED STATES on July 22, 2007. Female patient, 34 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414742-2
Physician from UNITED STATES reported Mannitol side effect on Aug 03, 2007. Female patient, 73 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414743-4
Mannitol side effect was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 34 years of age, was diagnosed with blood brain barrier defect, lymphoma
and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414753-7
Physician from UNITED STATES reported Mannitol side effect on Aug 03, 2007. Female patient, 54 years of age, was diagnosed with central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414754-9
Mannitol side effect was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 57 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: blood brain barrier defect, central nervous system lymphoma, maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414755-0
Physician from UNITED STATES reported Mannitol side effect on Aug 03, 2007. Female patient, 65 years of age, was diagnosed with blood brain barrier defect, lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy, visual disturbance. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414756-2
Mannitol side effect was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414757-4
Physician from UNITED STATES reported Mannitol side effect on Aug 03, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5813576-4
Mannitol side effect was reported by a Pharmacist from UNITED STATES on July 16, 2008. Male patient, 48 years of age, was treated with Mannitol. After drug was administered, patient experienced the following side effects: brain oedema, hyponatraemia, mental status changes. Mannitol dosage: unknown. Patient was hospitalized.
Mannitol Side Effects Report #4919977-0
Physician from JAPAN reported Mannitol side effect on Feb 08, 2006. Male patient, 15 years of age, was treated with Mannitol. After drug was administered, patient experienced the following side effects: hyperkalaemia, metabolic acidosis. Mannitol dosage: unknown.
Mannitol Side Effects Report #4956318-7
Mannitol side effect was reported by a Physician from JAPAN on Mar 13, 2006. Male patient, 15 years of age, weighting 119.0 lb, was diagnosed with reduction of increased intracranial pressure and was treated with Mannitol. After drug was administered, patient experienced the following side effects: condition aggravated, electrocardiogram qrs complex prolonged, electrocardiogram t wave peaked, hyperkalaemia, hyponatraemia, metabolic acidosis. Mannitol dosage: 300 ML, INTRAVENOUS DRIP. During the same period patient was treated with LACTATE RINGER SOLUTION, SEVOFLURANE, FENTANYL CITRATE, VECURONIUM BROMIDE.
Go to the top of the page
Mannitol Side Effects Report #5404976-5
Consumer or non-health professional from UNITED STATES reported Mannitol side effect on July 22, 2007. Female patient, 57 years of age, was diagnosed with brain operation, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE ECTION, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5404977-7
Mannitol side effect was reported by a Health Professional from UNITED STATES on July 22, 2007. Female patient, 65 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5404978-9
Health Professional from UNITED STATES reported Mannitol side effect on July 22, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: macular oedema, maculopathy, visual disturbance. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5404982-0
Mannitol side effect was reported by a Health Professional from UNITED STATES on July 22, 2007. Female patient, 66 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: macular oedema, maculopathy, visual acuity reduced. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5404984-4
Health Professional from UNITED STATES reported Mannitol side effect on July 22, 2007. Female patient, 73 years of age, was diagnosed with brain operation, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5404985-6
Mannitol side effect was reported by a Health Professional from UNITED STATES on July 22, 2007. Female patient, 34 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414742-2
Physician from UNITED STATES reported Mannitol side effect on Aug 03, 2007. Female patient, 73 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414743-4
Mannitol side effect was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 34 years of age, was diagnosed with blood brain barrier defect, lymphoma
and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Mannitol Side Effects Report #5414753-7
Physician from UNITED STATES reported Mannitol side effect on Aug 03, 2007. Female patient, 54 years of age, was diagnosed with central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414754-9
Mannitol side effect was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 57 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: blood brain barrier defect, central nervous system lymphoma, maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414755-0
Physician from UNITED STATES reported Mannitol side effect on Aug 03, 2007. Female patient, 65 years of age, was diagnosed with blood brain barrier defect, lymphoma
and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy, visual disturbance. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Mannitol Side Effects Report #5414756-2
Mannitol side effect was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE.
Mannitol Side Effects Report #5414757-4
Physician from UNITED STATES reported Mannitol side effect on Aug 03, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, lymphoma
and was treated with Mannitol. After drug was administered, patient experienced the following side effects: maculopathy. Mannitol dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Mannitol Side Effects Report #5813576-4
Mannitol side effect was reported by a Pharmacist from UNITED STATES on July 16, 2008. Male patient, 48 years of age, was treated with Mannitol. After drug was administered, patient experienced the following side effects: brain oedema, hyponatraemia, mental status changes. Mannitol dosage: unknown. Patient was hospitalized.
Mannitol Side Effects Report #4919977-0
Physician from JAPAN reported Mannitol side effect on Feb 08, 2006. Male patient, 15 years of age, was treated with Mannitol. After drug was administered, patient experienced the following side effects: hyperkalaemia, metabolic acidosis. Mannitol dosage: unknown.
Mannitol Side Effects Report #4956318-7
Mannitol side effect was reported by a Physician from JAPAN on Mar 13, 2006. Male patient, 15 years of age, weighting 119.0 lb, was diagnosed with reduction of increased intracranial pressure and was treated with Mannitol. After drug was administered, patient experienced the following side effects: condition aggravated, electrocardiogram qrs complex prolonged, electrocardiogram t wave peaked, hyperkalaemia, hyponatraemia, metabolic acidosis. Mannitol dosage: 300 ML, INTRAVENOUS DRIP. During the same period patient was treated with LACTATE RINGER SOLUTION, SEVOFLURANE, FENTANYL CITRATE, VECURONIUM BROMIDE.
0%